1Stoll G, Bendszus M. Infammation and atherosclerosis: novel insights into plaque formation and destabilization[J]. Stroke, 2006,37(7) :1923-1932.
2Funayama H, Ishikawa SE, Kubo N, et al. Increases in interleukin-6 and matrix metalloproteinase-9 in the infarctrelated coronary artery of acute myocardial infarction[J]. Circ J, 2004,68(5) :451-454.
3Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis:a comprehensive review of studies in mice[J]. Cardiovasc Res,2008,79( 3 ) :360 376.
6Fcldman LJ, Aguirre L, Ziol M, et al. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbils[J]. Circulation, 2000,101 (8): 908- 916.
7Caligiuri G, Rudling M, Ollivier V, et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice[J]. Mol Med, 2003,9(1/2) :10-17.
8Ueki K,Kondo T,Tseng YH, et al. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insuline resistance,and the metabolic syndrome in the mouse[J]. Proc Natl Acad Sci USA,2004,101(28):10422-10427.
9Heeschcn C,Dimmcler S, Harem CW, et al. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes[J]. Circulation, 2003,107(16) :2109-2114.
7Morita Y,Yamamura M,Kawashima M,et al.Differential in vitro effects of IL -4,IL-10,and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synovium[J].Rheumatol Int,2001,20(2):49 -54.
8Yamamoto T,Eckes B,Krieg T.Effect of interleukin-10 on the gene expression of type Ⅰ collagen,fibronectin,and decorin in human skin fibroblasts:differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1[J].Biochem Biophys Res Commun,2001,281 (1):200-205.
10Yang XD,Zhao LY,Zheng QS,et al.Effects of arginine vasopressin on growth of rat cardiac fibroblasts:role of V1 receptor[J].J Cardiovasc Pharmacol,2003,42(1):132-135.
4Mora C,Navarro JF. The role of inflammation as a pathogenic factor in the development of renal disease in diabetes[J]. Curr Diab Rep,2005,5(6) :399-401.
5Stoll G,Bendszus M.Infammation and atherosclerosis:novelinsights into plaque formation and destabilization [J].Stroke,2006,37(7):1923-1932.
6Kleemann R,Zadelaar S,Kooistra T.Cytokines and atherosclerosis:a comprehensive review of studies in mice [J].Cardiovasc Res,2008,79(3):360-376.
